SNXX
TQQQ Return RateThe biggest cost of drugs is drug R&D. Traditional drug R&D is like a manual workshop. Eli Lilly's AI factory is the steam engine of drug R&D, with efficiency and cost that crush other pharmaceutical companies. This is also why Eli Lilly's tirzepatide is more effective than NVO's.
Eli Lilly, Nvidia Launch LillyPod: Pharma's First 'AI Factory' in Indianapolis
Eli Lilly and Nvidia have launched LillyPod, the pharmaceutical industry's first AI Factory, in Indianapolis. This supercomputer, equipped with 1,016 Nvidia GPUs, aims to revolutionize drug discovery by enabling scientists to explore billions of hypotheses simultaneously. LillyPod is designed to handle the full AI lifecycle and is part of Lilly's strategy to enhance its AI capabilities. The initiative reflects a competitive push in the pharmaceutical sector, with other companies like Pfizer and Sanofi also partnering with Nvidia. Analysts are optimistic about Eli Lilly's stock, predicting a 23.4% upside potential.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
